EuroPCR 2023: Improving outcomes in mitral regurgitation
Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.
Related Videos
Procedural tip & tricks with Navitor across all valve sizes
Transcatheter Aortic Valves Implant
1-year VANTAGE TAVI outcomes in low/intermediate-risk patients
A Defining Moment Has To Start Somewhere. Why Not With You?
Webinar for Collaborative Management of HF Patients with MR
Transcatheter tricuspid valve repair: Cases, tips and tricks
M-TEER: Best treatment strategies for FMR AND DMR
Latest evidence in patient selection for T-TEER
TRENDING TOPICS
Procedural tip & tricks with Navitor across all valve sizes
1-year VANTAGE TAVI outcomes in low/intermediate-risk patients
Transcatheter Aortic Valves Implant
